Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Learn about Apple's iPhone 15.
Ready4Work focuses on the ins-and-outs of the job market.
Be Well: Best Skincare Products
Be Well: Fall Floral Arrangements
Salary is usually the deciding factor in a job search. Cheddar News' docuseries, "Ready 4 Work," highlights this and much more as it follows six people on their job-hunting journeys and how income is the main goal.
The Federal Trade Commission has begun notifying people that they may be entitled to some claims from Fortnite after a settlement from alleged deceptive business practices.
The Federal Reserve continues to meet over monetary policy but is expected to hold rates steady.
Eli Lilly is suing 10 medical spas, wellness clinics and compounding pharmacies across the country for allegedly selling cheaper counterfeit drugs.
Brenda LaManna, founder and president of Damselfly Flowers, and Warren Schorr, senior vice president with Crayola, joined Cheddar News to discuss how and why the famous Crayon company is launching an online flower business.
Ed Egilinsky, managing director and head of sales and distribution and alternative with Direxion, joined Cheddar News to discuss how short-term traders are preparing for any forward-looking guidance from the Federal Reserve about any potential rate hikes. Egilinsky also discussed how traders are looking at the overall banking sector for the short-term.
